Anthropic expands Claude AI tools for health & trials
Anthropic has expanded its Claude product line for healthcare providers, payers, consumers, and life sciences organisations, with new connectors, agent skills, and integrations that focus on clinical operations and regulated workflows.
The company said the update introduces Claude for Healthcare alongside an expanded Claude for Life Sciences package. Anthropic positioned both offerings as sets of tools and resources that connect Claude to sector-specific systems and data sources.
The healthcare release centres on what Anthropic calls HIPAA-ready products. It also adds tools that connect Claude to common datasets used across coverage checks, coding, credentialing, and biomedical literature.
Healthcare connectors
Anthropic said connectors allow users to give Claude access to external platforms directly. The company added connectors aimed at payers and providers. It framed the changes around information access across fragmented systems that often sit behind administrative processes.
Claude can now connect to the Centres for Medicare & Medicaid Services Coverage Database. That includes Local and National Coverage Determinations. Anthropic said this provides a route for verifying coverage requirements and reviewing documentation used in prior authorisation and claims appeals.
Anthropic also added an ICD-10 connector. It said Claude can look up diagnosis and procedure codes. The company linked this to medical coding and billing workflows.
A connector to the National Provider Identifier Registry is also part of the release. Anthropic said it can be used for provider verification, credentialing, directory management, and claims validation.
The company also pointed to existing connectors that healthcare organisations can access through Claude for Enterprise, including PubMed. Anthropic said PubMed provides access to more than 35 million pieces of biomedical literature. It said Claude can surface research and produce literature reviews when connected.
Agent skills
Anthropic added two new agent skills aimed at healthcare use cases. The first focuses on FHIR development, a standard for exchanging data between healthcare systems. The company said the skill targets developers who need to connect systems and reduce errors.
The second is a sample prior authorisation review skill. Anthropic described it as a template organisations can customise to internal policies and work patterns. The company said the skill can cross-reference coverage requirements, clinical guidelines, patient records, and appeal documents.
Administration focus
Anthropic set out a list of healthcare tasks it expects Claude to take on. These include reviews of prior authorisation requests, denied-claim appeals, and care coordination across patient messages, referrals, and handoffs.
It also highlighted product development for startups building healthcare applications on the Claude Developer Platform. The examples included tools for clinical documentation and chart review.
Consumer integrations
Anthropic also announced integrations that connect Claude to personal health data for individuals in the US. The company said subscribers on Claude Pro and Max can choose to grant secure access to lab results and health records through new HealthEx and Function connectors in beta.
Anthropic said Apple Health and Android Health Connect integrations are also rolling out in beta via the Claude mobile apps. The company said these connections allow Claude to summarise medical history, explain test results, spot patterns across health metrics, and prepare questions for medical appointments.
Anthropic said users must opt in, control what data they share, and can disconnect or edit permissions. It also said it does not use users' health data to train models.
Life sciences expansion
Alongside the healthcare package, Anthropic expanded Claude for Life Sciences into clinical trial operations and regulatory work. The company previously focused the product on preclinical research, including bioinformatics and protocol generation.
The update adds connectors to Medidata, ClinicalTrials.gov, ToolUniverse, bioRxiv and medRxiv, Open Targets, ChEMBL, and Owkin. Anthropic also listed existing connectors that remain part of the life sciences package, including Benchling, 10x Genomics, PubMed, BioRender, Synapse.org, and Wiley Scholar Gateway.
Anthropic said enabled Medidata Study Feasibility customers can use Claude to access historical trial enrolment information and site performance data. It also said ClinicalTrials.gov provides pipeline information relevant to recruitment planning, site selection, and protocol design.
The company said ToolUniverse offers access to more than 600 vetted scientific tools. It said connecting Claude to bioRxiv and medRxiv provides access to preprints ahead of formal publication. For discovery-stage work, it highlighted Open Targets and ChEMBL. It also referenced Owkin's Pathology Explorer agent, which analyses tissue images to detect cells and map tumours.
Anthropic also said its Benchling connector is now available via Claude.ai on the web, in addition to the desktop app. It said the connector supports secure access via single sign-on.
Trial and regulatory work
The life sciences update also adds agent skills for scientific problem selection, converting instrument data to Allotrope, and bioinformatics skills bundles for scVI-tools and Nextflow deployment. Anthropic also added a sample skill for clinical trial protocol draft generation. It said the drafts include endpoint recommendations and reflect regulatory pathways, the competitive landscape, and relevant FDA guidelines.
Anthropic said Claude can draft trial protocols, monitor trial operations using Medidata trial data, and prepare regulatory submissions. It said Claude can identify gaps in documents, draft responses to agency queries, and navigate FDA guidelines.
The company also said Claude is available on AWS, Google Cloud, and Microsoft. It listed consulting and services partners involved in AI adoption work for specialist roles, including Accenture, Deloitte, KPMG, PwC, and Slalom.